Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "AstraZeneca"

250 News Found

AstraZeneca flags off ‘AZ Forest’ a mass sapling plantation campaign in Bengaluru
Sustainability | March 07, 2022

AstraZeneca flags off ‘AZ Forest’ a mass sapling plantation campaign in Bengaluru

Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation


AstraZeneca and Neurimmune enter licencing agreement to develop and commercialise NI006
Biotech | March 01, 2022

AstraZeneca and Neurimmune enter licencing agreement to develop and commercialise NI006

Under the terms of the agreement, the upfront payment from Alexion to Neurimmune is US $ 30m


AstraZeneca partners with Honeywell to develop next-gen respiratory inhalers
Sustainability | February 22, 2022

AstraZeneca partners with Honeywell to develop next-gen respiratory inhalers

New inhalers would have near-zero Global Warming Potential propellant


Glenmark to commercialize AstraZeneca’s asthma drug in Columbia
Biotech | February 14, 2022

Glenmark to commercialize AstraZeneca’s asthma drug in Columbia

AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia


Clinical trials demonstrated safety of AstraZeneca and Sputnik Light vaccines combination
News | February 14, 2022

Clinical trials demonstrated safety of AstraZeneca and Sputnik Light vaccines combination

Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered


AstraZeneca expands ‘Young Health Programme’ to Bengaluru, this World Cancer Day
Healthcare | February 04, 2022

AstraZeneca expands ‘Young Health Programme’ to Bengaluru, this World Cancer Day

It has signed an MoU with Plan India to expand its reach to Karnataka


AstraZeneca India appoints Ram Mudaliar as India lead of their CDI division
People | January 20, 2022

AstraZeneca India appoints Ram Mudaliar as India lead of their CDI division

Ram’s appointment follows the launch of the CDI India division in October 2021.


AstraZeneca and Scorpian Therapeutics partner to target novel cancer treatments
Biotech | January 14, 2022

AstraZeneca and Scorpian Therapeutics partner to target novel cancer treatments

The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival


AstraZeneca studies show its booster effective against all variants
News | January 13, 2022

AstraZeneca studies show its booster effective against all variants

New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha, Gamma and Omicron variants following third dose booster with Vaxzevria


AstraZeneca and Neurimmune to develop and commercialise NI006
Biotech | January 07, 2022

AstraZeneca and Neurimmune to develop and commercialise NI006

Investigational human monoclonal antibody in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy, a systemic, progressive and fatal condition